A nomogram based on combining systemic and hepatic inflammation markers for predicting microscopic bile duct tumour thrombus in hepatocellular carcinoma

Table 1 Clinicopathological features

Variable	without BDTT (n = 677)	with micro-BDTT (n = 46)	P-value
Age (years)			0.552
> 60	220	33
≤60	457	13
Sex			0.483
Male	571	37
Female	106	9
WBC (*10⁹/ L)	6.17 ± 2.39	5.92 ± 2.52	0.181
Neutrophil (*10⁹/L)	3.87 ± 2.15	3.62 ± 1.93	0.961
Lymphocyte (*10⁹/ L)	1.68 ± 0.69	1.56 ± 0.70	0.872
Monocyte (*10⁹/ L)	0.48 ± 0.24	0.42 ± 0.22	0.594
Platelets (*10⁹/ L)	177.31 ± 75.69	175.59 ± 87.49	0.668
ALB (U/L)
> 40	498	25	0.005
≤ 40	179	21
ALP (U/L)			0.000
> 125	138	26
≤ 125	539	20
γ-GT (U/L)			0.000
> 60	357	38
≤ 60	320	8
DB (μmol/L)			0.000
> 8	130	22
≤ 8	547	24
ALT (U/L)			0.290
> 50	205	18
≤ 50	472	28
HbsAg			0.916
+ -	570	39
-	107	7
γ-GT/ALT	2.53 ± 2.86	6.29 ± 5.28	0.000
NLR	2.79 ± 2.87	2.58 ± 1.53	0.339
PLR	116.48 ± 62.42	119.62 ± 48.34	0.222
LMR	4.10 ± 2.64	4.56 ± 2.74	0.146
PNI	50.99 ± 6.27	46.70 ± 7.80	0.178
Child-Pugh			0.465
A	647	45
B-C	30	1
AFP (μg/L)			0.002
≥ 400	244	27
< 400	433	19
Tumor size (cm)			0.401
> 5	278	30
≤ 5	399	16
Tumor number (n, %)			0.079
1	467	26
> 1	210	20

ISSN: 1471-2407